Literature DB >> 29746317

Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort.

Felicia C Chow1,2, Michael R Wilson1,3, Kunling Wu4, Ronald J Ellis5, Ronald J Bosch4, Benjamin P Linas6.   

Abstract

OBJECTIVE: To investigate the incidence of first-ever stroke/transient ischemic attack (TIA) and associated risk factors in a cohort of persons living with HIV infection (PLWH).
DESIGN: Observational cohort study
METHODS: We determined incidence rates of first-ever stroke/TIA in PLWH after ART initiation from the AIDS Clinical Trials Group ALLRT cohort and its parent trials. Poisson regression models evaluated baseline and time-varying covariates as risk factors for stroke/TIA.
RESULTS: The incidence rate of stroke/TIA was 1.69 per 1000 person-years. Incidence rates were highest in women (2.88 stroke/TIAs per 1000 person-years compared with 1.40 per 1000 person-years in men) and non-Hispanic Blacks (2.51 stroke/TIAs per 1000 person-years compared with 0.77 per 1000 person-years in Hispanic/other race/ethnicities and 1.56 per 1000 person-years in whites). In a multivariable model, we found a significant age-by-sex interaction (P = 0.01). The higher risk of stroke/TIA in women was more pronounced at younger ages, whereas older age conferred a greater increase in stroke/TIA risk in men than women. Other risk factors for stroke/TIA included hypertension, higher LDL, and HIV RNA greater than 200 copies/ml. Overweight/obese BMI and higher CD4+:CD8+ ratio protected against stroke/TIA.
CONCLUSION: Women and non-Hispanic Blacks living with HIV had the highest incidence rates of stroke/TIA. A concerted effort must be made to include PLWH from these at-risk groups in observational and interventional studies aimed at understanding stroke mechanisms and reducing stroke risk in HIV infection. Strategies to modify stroke risk in PLWH should employ a multipronged approach targeting vascular risk factors and engaging and retaining patients in HIV care.

Entities:  

Mesh:

Year:  2018        PMID: 29746317      PMCID: PMC5955006          DOI: 10.1097/QAD.0000000000001799

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  35 in total

1.  Differences in the role of black race and stroke risk factors for first vs. recurrent stroke.

Authors:  George Howard; Brett M Kissela; Dawn O Kleindorfer; Leslie A McClure; Elsayed Z Soliman; Suzanne E Judd; J David Rhodes; Mary Cushman; Claudia S Moy; Kara A Sands; Virginia J Howard
Journal:  Neurology       Date:  2016-01-20       Impact factor: 9.910

2.  AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.

Authors:  Marlene Smurzynski; Ann C Collier; Susan L Koletar; Ronald J Bosch; Kunling Wu; Barbara Bastow; Constance A Benson
Journal:  HIV Clin Trials       Date:  2008 Jul-Aug

3.  Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals.

Authors:  Felicia C Chow; W John Boscardin; Claire Mills; Nerissa Ko; Courtney Carroll; Richard W Price; Steven Deeks; Farzaneh A Sorond; Priscilla Y Hsue
Journal:  AIDS       Date:  2016-01-02       Impact factor: 4.177

Review 4.  Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators.

Authors:  Pirkko L Härkönen; H Kalervo Väänänen
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

5.  Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study.

Authors:  Barbara Hasse; Bruno Ledergerber; Hansjakob Furrer; Manuel Battegay; Bernhard Hirschel; Matthias Cavassini; Barbara Bertisch; Enos Bernasconi; Rainer Weber
Journal:  Clin Infect Dis       Date:  2011-10-13       Impact factor: 9.079

6.  Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women.

Authors:  Kathleen V Fitch; Suman Srinivasa; Suhny Abbara; Tricia H Burdo; Kenneth C Williams; Peace Eneh; Janet Lo; Steven K Grinspoon
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

7.  Elevated D-dimer is independently associated with endothelial dysfunction: a cross-sectional study in HIV-infected adults on antiretroviral therapy.

Authors:  Corrilynn O Hileman; Chris T Longenecker; Teresa L Carman; Ginger L Milne; Danielle E Labbato; Norma J Storer; Cynthia A White; Grace A McComsey
Journal:  Antivir Ther       Date:  2012-08-09       Impact factor: 1.679

8.  Cardiovascular outcomes among HIV-infected veterans receiving atazanavir.

Authors:  Joanne LaFleur; Adam P Bress; Lisa Rosenblatt; Jacob Crook; Paul E Sax; Joel Myers; Corey Ritchings
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

9.  Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio.

Authors:  Sergio Serrano-Villar; María Jesús Pérez-Elías; Fernando Dronda; José Luis Casado; Ana Moreno; Ana Royuela; José Antonio Pérez-Molina; Talia Sainz; Enrique Navas; José Manuel Hermida; Carmen Quereda; Santiago Moreno
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

10.  HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.

Authors:  Sergio Serrano-Villar; Talia Sainz; Sulggi A Lee; Peter W Hunt; Elizabeth Sinclair; Barbara L Shacklett; April L Ferre; Timothy L Hayes; Ma Somsouk; Priscilla Y Hsue; Mark L Van Natta; Curtis L Meinert; Michael M Lederman; Hiroyu Hatano; Vivek Jain; Yong Huang; Frederick M Hecht; Jeffrey N Martin; Joseph M McCune; Santiago Moreno; Steven G Deeks
Journal:  PLoS Pathog       Date:  2014-05-15       Impact factor: 6.823

View more
  10 in total

Review 1.  Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature.

Authors:  Charles Muiruri; Chris T Longenecker; Eric G Meissner; Nwora Lance Okeke; April C Pettit; Kevin Thomas; Eric Velazquez; Gerald S Bloomfield
Journal:  Prog Cardiovasc Dis       Date:  2020-02-11       Impact factor: 8.194

2.  Prevalence and Characteristics of HIV-Associated Stroke in a Tertiary Hospital Setting in South Africa.

Authors:  Craig Corbett; Naeem Brey; Richard D Pitcher; Suzanne O'Hagan; Tonya M Esterhuizen; Felicia C Chow; Eric H Decloedt
Journal:  Neurology       Date:  2022-06-03       Impact factor: 11.800

3.  Elevated Microparticle Tissue Factor Activity Is Associated With Carotid Artery Plaque in HIV-Infected Women.

Authors:  Juan Lin; Xiaonan Xue; Kathryn Anastos; Mardge H Cohen; Stephen J Gange; Jason M Lazar; Chenglong Liu; Wendy J Mack; Phyllis C Tien; Cathy Tilley; Howard N Hodis; Alan L Landay; Russell P Tracy; Robert C Kaplan; David B Hanna
Journal:  J Acquir Immune Defic Syndr       Date:  2019-05-01       Impact factor: 3.771

4.  HIV Viremia and Risk of Stroke Among People Living with HIV Who Are Using Antiretroviral Therapy.

Authors:  Barbara N Harding; Tigran Avoundjian; Susan R Heckbert; Bridget M Whitney; Robin M Nance; Stephanie A Ruderman; Rizwan Kalani; David L Tirschwell; Emily L Ho; Kyra J Becker; Joseph Zunt; Felicia Chow; Andrew Huffer; W Christopher Mathews; Joseph Eron; Richard D Moore; Christina M Marra; Greer Burkholder; Michael S Saag; Mari M Kitahata; Heidi M Crane; Joseph C Delaney
Journal:  Epidemiology       Date:  2021-05-01       Impact factor: 4.860

Review 5.  HIV Associated Risk Factors for Ischemic Stroke and Future Perspectives.

Authors:  Saifudeen Ismael; Mohammad Moshahid Khan; Prashant Kumar; Sunitha Kodidela; Golnoush Mirzahosseini; Santhosh Kumar; Tauheed Ishrat
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

6.  Incidence of stroke in patients with HIV infection: A population-based study in Taiwan.

Authors:  Hui-Lin Lin; Chih-Hsin Muo; Cheng-Yu Lin; Hsuan-Ju Chen; Pei-Chun Chen
Journal:  PLoS One       Date:  2019-05-22       Impact factor: 3.240

Review 7.  Sex Differences in Non-AIDS Comorbidities Among People With Human Immunodeficiency Virus.

Authors:  Renee A Pond; Lauren F Collins; Cecile D Lahiri
Journal:  Open Forum Infect Dis       Date:  2021-11-03       Impact factor: 4.423

Review 8.  HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women.

Authors:  Laszlo Kovacs; Taylor C Kress; Eric J Belin de Chantemèle
Journal:  JACC Basic Transl Sci       Date:  2022-01-19

9.  Sex- and Poverty-Specific Patterns in Cardiovascular Disease Mortality Associated With Human Immunodeficiency Virus, New York City, 2007-2017.

Authors:  David B Hanna; Chitra Ramaswamy; Robert C Kaplan; Jorge R Kizer; Demetre Daskalakis; Kathryn Anastos; Sarah L Braunstein
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 20.999

10.  Factors associated with worse cerebrovascular function in aging women with and at risk for HIV.

Authors:  Felicia C Chow; Yifei Ma; Maura Manion; Adam Rupert; Geralyn Lambert-Messerlian; Cheryl D Bushnell; Marcelle I Cedars; Irini Sereti; Farzaneh A Sorond; Priscilla Y Hsue; Phyllis C Tien
Journal:  AIDS       Date:  2021-02-02       Impact factor: 4.632

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.